InspireMD (NSPR) – Hot FDA News
-
InspireMD (NSPR) Reports Preliminary 2-Yr Follow-Up Results from PARADIGM Clinical Study Using CGuard EPS
-
InspireMD (NSPR) Gains; Reports Positve 6-Month Data on CGuardTM CARENET Trial
-
Back to NSPR Stock Lookup